1
Country: Denmark | Funding: $721.3M
Transmedics is a medical device company involved in the design and production of transplant devices.
Transmedics is a medical device company involved in the design and production of transplant devices.
2
Country: USA | Funding: $456M
EGenesis focuses on leveraging genome editing technology to deliver safe and effective human transplantable cells, tissues, and organs.
EGenesis focuses on leveraging genome editing technology to deliver safe and effective human transplantable cells, tissues, and organs.
3
Country: USA | Funding: $405.9M
Magenta Therapeutics is a new biotechnology company developing therapeutics that unlock the power of stem cell biology. Magenta is focused on improving the patient experience in transplant medicine, with the goal of bringing this lifesaving procedure to more patients.
Magenta Therapeutics is a new biotechnology company developing therapeutics that unlock the power of stem cell biology. Magenta is focused on improving the patient experience in transplant medicine, with the goal of bringing this lifesaving procedure to more patients.
4
Country: UK | Funding: $207M
OrganOx develops a revolutionary device for storing livers at normal body temperatures for extended periods of time. Following extensive pre-clinical studies and the successful completion of clinical studies, the product is now commercially available within the EU.
OrganOx develops a revolutionary device for storing livers at normal body temperatures for extended periods of time. Following extensive pre-clinical studies and the successful completion of clinical studies, the product is now commercially available within the EU.
5
Country: USA | Funding: $112.3M
Insight Molecular Diagnostics (iMDx) develops and provides diagnostic tests for oncology. The company is developing three genetic tests: blood tests for breast and lung cancer and a urine test for bladder cancer. iMDx has also developed a blood-based transplant monitoring test that quantifies the concentration of donor cell-free DNA (dd-cfDNA) after transplantation. The company partners with biotech research laboratories and supplies them with tests intended exclusively for research purposes in oncology and transplantation research projects.
Insight Molecular Diagnostics (iMDx) develops and provides diagnostic tests for oncology. The company is developing three genetic tests: blood tests for breast and lung cancer and a urine test for bladder cancer. iMDx has also developed a blood-based transplant monitoring test that quantifies the concentration of donor cell-free DNA (dd-cfDNA) after transplantation. The company partners with biotech research laboratories and supplies them with tests intended exclusively for research purposes in oncology and transplantation research projects.
6
Country: USA | Funding: $25.8M
Paragonix Technologies is a medical device company specialized in organ preservation devices for the improvement of donor organ quality.
Paragonix Technologies is a medical device company specialized in organ preservation devices for the improvement of donor organ quality.
7
Country: Sweden | Funding: €50K
XVIVO Perfusion is a medical technology company. We are firmly rooted in medical science and our core business is in ex vivo organ preservation. We are focused on developing optimized solutions for organ, tissue and cell preservation and perfusion in connection with transplantation. We have more than 15 years of experience within the transplant industry and are dedicated to providing more effective, clinically proven and innovative products that both increase the availability of acceptable donor organs and improve survival after transplantation.
XVIVO Perfusion is a medical technology company. We are firmly rooted in medical science and our core business is in ex vivo organ preservation. We are focused on developing optimized solutions for organ, tissue and cell preservation and perfusion in connection with transplantation. We have more than 15 years of experience within the transplant industry and are dedicated to providing more effective, clinically proven and innovative products that both increase the availability of acceptable donor organs and improve survival after transplantation.
